Most Brokerages Remain Bullish On Sun Pharma After Q1 Results
Sun Pharma headquarters in Mumbai. Sun Pharma’s robust Q1 results comes at a time India’s pharma industry grew at its slowest pace in five years in the April-June period. (Photographer: Kanishka Sonthalia/Bloomberg)

Most Brokerages Remain Bullish On Sun Pharma After Q1 Results

Most analysts maintained their bullish rating on Sun Pharmaceutical Industries Ltd. after profit of India’s largest drugmaker beat estimates in the quarter ended June.The company’s net profit rose ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.